Source:http://linkedlifedata.com/resource/pubmed/id/20021567
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-12-21
|
pubmed:abstractText |
Emerging data establish dyslipidemia as a significant contributor to the development of diabetic neuropathy. In this review, we discuss how separate metabolic imbalances, including hyperglycemia and hyperlipidemia, converge on mechanisms leading to oxidative stress in dorsal root ganglia (DRG) sensory neurons. We conclude with suggestions for novel therapeutic strategies to prevent or reverse diabetes-induced nerve degeneration.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1529-8027
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-67
|
pubmed:meshHeading |
pubmed-meshheading:20021567-Animals,
pubmed-meshheading:20021567-Diabetic Neuropathies,
pubmed-meshheading:20021567-Ganglia, Spinal,
pubmed-meshheading:20021567-Humans,
pubmed-meshheading:20021567-Hyperglycemia,
pubmed-meshheading:20021567-Hyperlipidemias,
pubmed-meshheading:20021567-Oxidative Stress,
pubmed-meshheading:20021567-Sensory Receptor Cells
|
pubmed:year |
2009
|
pubmed:articleTitle |
Hyperlipidemia: a new therapeutic target for diabetic neuropathy.
|
pubmed:affiliation |
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. andreav@umich.edu
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|